cefuroxime has been researched along with MODS in 4 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In addition, septic shock occurred in 6 cases (2." | 2.73 | Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime. ( Falagas, M; Falagas, ME; Geroulanos, S; Karatza, D; Kriaras, I; Mastoraki, E; Michalopoulos, A; Mouchtouri, E, 2008) |
| "Cefuroxime was chosen as the PBP-3-active antibiotic and tobramycin represented the aminoglycosides." | 1.56 | Mode of bacterial killing affects the inflammatory response and associated organ dysfunctions in a porcine E. coli intensive care sepsis model. ( Larsson, A; Lipcsey, M; Maudsdotter, L; Sjölin, J; Skorup, P, 2020) |
| " The pharmacokinetic profile of cefuroxime exhibited both one and two compartmental distribution." | 1.35 | Effect of severity disease on the pharmacokinetics of cefuroxime in children with multiple organ system failure. ( Asseff, IL; Guillé, GP; Olguín, HJ; Pérez, AG; Quesada, AC; Saldaña, NG; Vieyra, AC, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skorup, P | 2 |
| Maudsdotter, L | 2 |
| Lipcsey, M | 2 |
| Larsson, A | 2 |
| Sjölin, J | 2 |
| Tano, E | 1 |
| Castegren, M | 1 |
| Mastoraki, E | 1 |
| Michalopoulos, A | 1 |
| Kriaras, I | 1 |
| Mouchtouri, E | 1 |
| Falagas, ME | 1 |
| Falagas, M | 1 |
| Karatza, D | 1 |
| Geroulanos, S | 1 |
| Olguín, HJ | 1 |
| Asseff, IL | 1 |
| Vieyra, AC | 1 |
| Pérez, AG | 1 |
| Saldaña, NG | 1 |
| Quesada, AC | 1 |
| Guillé, GP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICU[NCT05511129] | 1,053 participants (Actual) | Observational | 2022-05-12 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for cefuroxime and MODS
| Article | Year |
|---|---|
Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefuroxime; Coronary Artery Bypass; Drug | 2008 |
3 other studies available for cefuroxime and MODS
| Article | Year |
|---|---|
Mode of bacterial killing affects the inflammatory response and associated organ dysfunctions in a porcine E. coli intensive care sepsis model.
Topics: Animals; Cefuroxime; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infectio | 2020 |
Dynamics of Endotoxin, Inflammatory Variables, and Organ Dysfunction After Treatment With Antibiotics in an Escherichia coli Porcine Intensive Care Sepsis Model.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Disease Models, Animal; Drug Therapy, Combination; Endot | 2018 |
Effect of severity disease on the pharmacokinetics of cefuroxime in children with multiple organ system failure.
Topics: Adolescent; Alanine Transaminase; Algorithms; Area Under Curve; Aspartate Aminotransferases; Cefurox | 2008 |